Cargando…

Next Generation Natural Killer Cells for Cancer Immunotherapy

In recent years, immunotherapy for cancer has become mainstream with several products now authorized for therapeutic use in the clinic and are becoming the standard of care for some malignancies. Chimeric antigen receptor (CAR)-T cell therapies have demonstrated substantial efficacy for the treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Fiorella, Fredericks, Nathaniel, Snowden, Andrew, Allegrezza, Michael J., Moreno-Nieves, Uriel Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202478/ https://www.ncbi.nlm.nih.gov/pubmed/35720306 http://dx.doi.org/10.3389/fimmu.2022.886429

Ejemplares similares

Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
por: Ben-Shmuel, Aviad, et al.
Publicado: (2020)

Natural killer cells: the next wave in cancer immunotherapy
por: Chen, Xin, et al.
Publicado: (2022)

Natural Killer T Cells in Cancer Immunotherapy
por: Nair, Shiny, et al.
Publicado: (2017)

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
por: Rezvani, Katayoun, et al.
Publicado: (2015)

New Directions for Natural Killer T Cells in the Immunotherapy of Cancer
por: Teyton, Luc
Publicado: (2017)

Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy
por: Shaver, Kari A., et al.
Publicado: (2021)

Harnessing natural killer cells to develop next‐generation cellular immunotherapy
por: Liu, Siyao, et al.
Publicado: (2022)

Modeling Natural Killer Cell Targeted Immunotherapies
por: Lopez-Lastra, Silvia, et al.
Publicado: (2017)

Targeting Natural Killer Cells for Tumor Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017)

Cord-Blood Natural Killer Cell-Based Immunotherapy for Cancer
por: Zhao, Xiaoyan, et al.
Publicado: (2020)

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies
por: Barnes, Samantha A., et al.
Publicado: (2021)

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
por: Mehta, Rohtesh S., et al.
Publicado: (2018)

Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature
por: Lowry, Lacy E., et al.
Publicado: (2017)

Natural Killer Cell Immunotherapy: From Bench to Bedside
por: Domogala, Anna, et al.
Publicado: (2015)

Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy
por: Gaggero, Silvia, et al.
Publicado: (2021)

Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy
por: Shissler, Susannah C., et al.
Publicado: (2017)

Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies
por: Lam, Pui Yeng, et al.
Publicado: (2017)

Pathological Mobilization and Activities of Dendritic Cells in Tumor-Bearing Hosts: Challenges and Opportunities for Immunotherapy of Cancer
por: Tesone, Amelia J., et al.
Publicado: (2013)

The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
por: Paul, Sourav, et al.
Publicado: (2017)

Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer
por: Nersesian, Sarah, et al.
Publicado: (2019)

Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
por: Hu, Weilei, et al.
Publicado: (2019)

The Natural Killer–Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy
por: Peterson, Erin E., et al.
Publicado: (2021)

Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy
por: Wu, Feifeng, et al.
Publicado: (2021)

Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy
por: Zhang, Minchuan, et al.
Publicado: (2023)

Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target
por: Gingrich, Alicia A., et al.
Publicado: (2021)

Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
por: Salomon, Ran, et al.
Publicado: (2022)

Humanized Mouse Models for the Advancement of Innate Lymphoid Cell-Based Cancer Immunotherapies
por: Horowitz, Nina B., et al.
Publicado: (2021)

Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review
por: Uppendahl, Locke D., et al.
Publicado: (2018)

Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies
por: Market, Marisa, et al.
Publicado: (2020)

Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer
por: Yang, Xinyi, et al.
Publicado: (2022)

Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy
por: Kang, Lin, et al.
Publicado: (2013)

Killer Immunoglobulin-Like Receptor Allele Determination Using Next-Generation Sequencing Technology
por: Maniangou, Bercelin, et al.
Publicado: (2017)

Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
por: Yu, Tao, et al.
Publicado: (2022)

Editorial: Next generation γδ T cell-based tumor immunotherapy
por: Tan, Andy Hee-Meng, et al.
Publicado: (2022)

Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
por: Eguizabal, Cristina, et al.
Publicado: (2014)

Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
por: Chester, Cariad, et al.
Publicado: (2015)

Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy
por: Muntasell, Aura, et al.
Publicado: (2017)

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)

Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies
por: Hofer, Erhard, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u80ue440onho3d3eb1a80bsmeq